Organon Llc Drug Patent Portfolio
Organon Llc owns 8 orange book drugs protected by 54 US patents with Xaciato having the least patent protection, holding only 1 patent. And Asmanex Twisthaler with maximum patent protection, holding 21 patents. Given below is the list of Organon Llc's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11129896 | Topical formulations and treatments | 22 Sep, 2036 | Active |
| US7618649 | Extended release oral dosage composition | 19 Jun, 2021 | Expired |
| US6709676 | Extended release oral dosage composition | 18 Feb, 2021 | Expired |
| US7618649 | Extended release oral dosage composition | 19 Dec, 2020 | Expired |
| US8187630 | Extended release oral dosage composition | 19 Dec, 2020 | Expired |
| US7067502 | Combinations of formoterol and mometasone furoate for asthma | 21 Nov, 2020 | Expired |
| US7566705 | Combination of formoterol and mometasone furoate for asthma | 21 Nov, 2020 | Expired |
| US7067502 | Combinations of formoterol and mometasone furoate for asthma | 21 May, 2020 | Expired |
| US7566705 | Combination of formoterol and mometasone furoate for asthma | 08 May, 2020 | Expired |
| US6100274 | 8-chloro-6,11-dihydro-11- ](4-piperidylidine)-5H-benzo[5,6]cyclohepta[1,2-bpyridine oral compositions | 07 Jan, 2020 | Expired |
| US6100274 | 8-chloro-6,11-dihydro-11- ](4-piperidylidine)-5H-benzo[5,6]cyclohepta[1,2-bpyridine oral compositions | 07 Jul, 2019 | Expired |
| US5994329 | Method for inhibiting bone resorption | 17 Jan, 2019 | Expired |
| US6503537 | Preparation of powder agglomerates | 17 Sep, 2018 | Expired |
| US8173172 | Preparation of powder agglomerates | 17 Sep, 2018 | Expired |
| US5994329 | Method for inhibiting bone resorption | 17 Jul, 2018 | Expired |
| US6127353 | Mometasone furoate monohydrate, process for making same and pharmaceutical compositions | 03 Apr, 2018 | Expired |
| US6503537 | Preparation of powder agglomerates | 17 Mar, 2018 | Expired |
| US8173172 | Preparation of powder agglomerates | 17 Mar, 2018 | Expired |
| US6127353 | Mometasone furoate monohydrate, process for making same and pharmaceutical compositions | 03 Oct, 2017 | Expired |
| US6068832 | Chlorofluorocarbon-free mometasone furoate aerosol formulations | 27 Aug, 2017 | Expired |
| US6240918 | Powdered medication inhaler | 20 Aug, 2017 | Expired |
| US6240918 | Powdered medication inhaler | 20 Feb, 2017 | Expired |
| US5829434 | Inhaler for powdered medications | 03 May, 2016 | Expired |
| US5829434 | Inhaler for powdered medications | 03 Nov, 2015 | Expired |
| US7214683 | Compositions of descarboethoxyloratadine | 30 Jun, 2015 | Expired |
| US7214684 | Methods for the treatment of allergic rhinitis | 30 Jun, 2015 | Expired |
| US5687710 | Inhaler for powdered medications having spiral deagglomeration chamber | 18 May, 2015 | Expired |
| US7214683 | Compositions of descarboethoxyloratadine | 30 Dec, 2014 | Expired |
| US7214684 | Methods for the treatment of allergic rhinitis | 30 Dec, 2014 | Expired |
| US5687710 | Inhaler for powdered medications having spiral deagglomeration chamber | 18 Nov, 2014 | Expired |
| US5889015 | Use of mometasone furoate for treating lower airway passage and lung diseases | 27 Jul, 2014 | Expired |
| US6057307 | Use of mometasone furoate for treating airway passage and lung diseases | 27 Jul, 2014 | Expired |
| US6365581 | Use of mometasone furoate for treating airway passage and lung diseases | 27 Jul, 2014 | Expired |
| US6677322 | Use of mometasone furoate for treating airway passage and lung diseases | 27 Jul, 2014 | Expired |
| US6949532 | Use of mometasone furoate for treating airway passage and lung diseases | 27 Jul, 2014 | Expired |
| US5837699 | Use of mometasone furoate for treating upper airway passage diseases | 27 Jul, 2014 | Expired |
| US6723713 | Use of mometasone furoate for treating upper airway diseases | 27 Jul, 2014 | Expired |
| US5889015 | Use of mometasone furoate for treating lower airway passage and lung diseases | 27 Jan, 2014 | Expired |
| US6057307 | Use of mometasone furoate for treating airway passage and lung diseases | 27 Jan, 2014 | Expired |
| US6365581 | Use of mometasone furoate for treating airway passage and lung diseases | 27 Jan, 2014 | Expired |
| US6677322 | Use of mometasone furoate for treating airway passage and lung diseases | 27 Jan, 2014 | Expired |
| US6949532 | Use of mometasone furoate for treating airway passage and lung diseases | 27 Jan, 2014 | Expired |
| US6677323 | Use of mometasone furoate for treating airway passage and lung diseases | 27 Jan, 2014 | Expired |
| US5837699 | Use of mometasone furoate for treating upper airway passage diseases | 27 Jan, 2014 | Expired |
| US6723713 | Use of mometasone furoate for treating upper airway diseases | 27 Jan, 2014 | Expired |
| US5358941 | Dry mix formulation for bisphosphonic acids with lactose | 02 Jun, 2013 | Expired |
| US5681590 | Dry mix formulation for bisphosphonic acids | 02 Jun, 2013 | Expired |
| US6090410 | Dry mix formulation for bisphosphonic acids | 02 Jun, 2013 | Expired |
| US5298520 | Triazole containing indole derivatives | 29 Dec, 2012 | Expired |
| US5394868 | Inhalation device for powdered medicaments | 25 Dec, 2012 | Expired |
| US5358941 | Dry mix formulation for bisphosphonic acids with lactose | 02 Dec, 2012 | Expired |
| US5681590 | Dry mix formulation for bisphosphonic acids | 02 Dec, 2012 | Expired |
| US6090410 | Dry mix formulation for bisphosphonic acids | 02 Dec, 2012 | Expired |
| US5602162 | Imidazole, triazole and tetrazole derivatives | 28 Jul, 2012 | Expired |
Latest Legal Activities on Organon Llc's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Organon Llc.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
|
Expire Patent
Critical
| 01 Jul, 2024 | US8187630 |
|
Maintenance Fee Reminder Mailed
Critical
| 15 Jan, 2024 | US8187630 |
|
Change in Power of Attorney (May Include Associate POA)
Critical
| 29 Dec, 2021 | US11129896 |
|
Email Notification
Critical
| 29 Dec, 2021 | US11129896 |
|
Correspondence Address Change
Critical
| 27 Dec, 2021 | US11129896 |
|
Expire Patent
Critical
| 20 Dec, 2021 | US7618649 |
|
Recordation of Patent Grant Mailed
Critical
| 28 Sep, 2021 | US11129896 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 28 Sep, 2021 | US11129896 |
|
Email Notification
Critical
| 09 Sep, 2021 | US11129896 |
|
Issue Notification Mailed
Critical
| 08 Sep, 2021 | US11129896 |
|
Expire Patent
Critical
| 30 Aug, 2021 | US7566705 |
|
Application Is Considered Ready for Issue
Critical
| 25 Aug, 2021 | US11129896 |
| Dispatch to FDC | 25 Aug, 2021 | US11129896 |
|
Issue Fee Payment Verified
Critical
| 23 Aug, 2021 | US11129896 |
|
Issue Fee Payment Received
Critical
| 23 Aug, 2021 | US11129896 |
Organon Llc's Drug Patent Litigations
Organon Llc's drugs have been subject to various legal proceedings, including patent litigations. The earliest legal proceeding was initiated on Dec 09, 2004, against patent number US7214683. The petitioner , challenged the validity of this patent, with ABERG et al as the respondent. Click below to track the latest information on how companies are challenging Organon Llc's patents.
| Patent | Proceeding Filing Date | Status | Respondent | Petitioner |
|---|---|---|---|---|
 | ||||
| US7214683 | December, 2004 |
Decision
(24 Mar, 2005)
| ABERG et al | |
Organon Llc's Family Patents
Organon Llc Drug List
Given below is the complete list of Organon Llc's drugs and the patents protecting them.
1. Asmanex Hfa
Asmanex Hfa is protected by 7 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US6068832 | Chlorofluorocarbon-free mometasone furoate aerosol formulations |
27 Aug, 2017
(7 years ago)
| Expired |
| US5889015
(Pediatric)
| Use of mometasone furoate for treating lower airway passage and lung diseases |
27 Jul, 2014
(10 years ago)
| Expired |
| US6057307
(Pediatric)
| Use of mometasone furoate for treating airway passage and lung diseases |
27 Jul, 2014
(10 years ago)
| Expired |
| US6365581
(Pediatric)
| Use of mometasone furoate for treating airway passage and lung diseases |
27 Jul, 2014
(10 years ago)
| Expired |
| US5889015 | Use of mometasone furoate for treating lower airway passage and lung diseases |
27 Jan, 2014
(10 years ago)
| Expired |
| US6057307 | Use of mometasone furoate for treating airway passage and lung diseases |
27 Jan, 2014
(10 years ago)
| Expired |
| US6365581 | Use of mometasone furoate for treating airway passage and lung diseases |
27 Jan, 2014
(10 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Asmanex Hfa's drug page
2. Asmanex Twisthaler
Asmanex Twisthaler is protected by 21 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US6503537
(Pediatric)
| Preparation of powder agglomerates |
17 Sep, 2018
(6 years ago)
| Expired |
| US8173172
(Pediatric)
| Preparation of powder agglomerates |
17 Sep, 2018
(6 years ago)
| Expired |
| US6503537 | Preparation of powder agglomerates |
17 Mar, 2018
(6 years ago)
| Expired |
| US8173172 | Preparation of powder agglomerates |
17 Mar, 2018
(6 years ago)
| Expired |
| US6240918
(Pediatric)
| Powdered medication inhaler |
20 Aug, 2017
(7 years ago)
| Expired |
| US6240918 | Powdered medication inhaler |
20 Feb, 2017
(7 years ago)
| Expired |
| US5829434
(Pediatric)
| Inhaler for powdered medications |
03 May, 2016
(8 years ago)
| Expired |
| US5829434 | Inhaler for powdered medications |
03 Nov, 2015
(9 years ago)
| Expired |
| US5687710
(Pediatric)
| Inhaler for powdered medications having spiral deagglomeration chamber |
18 May, 2015
(9 years ago)
| Expired |
| US5687710 | Inhaler for powdered medications having spiral deagglomeration chamber |
18 Nov, 2014
(10 years ago)
| Expired |
| US5889015
(Pediatric)
| Use of mometasone furoate for treating lower airway passage and lung diseases |
27 Jul, 2014
(10 years ago)
| Expired |
| US6057307
(Pediatric)
| Use of mometasone furoate for treating airway passage and lung diseases |
27 Jul, 2014
(10 years ago)
| Expired |
| US6365581
(Pediatric)
| Use of mometasone furoate for treating airway passage and lung diseases |
27 Jul, 2014
(10 years ago)
| Expired |
| US6677322
(Pediatric)
| Use of mometasone furoate for treating airway passage and lung diseases |
27 Jul, 2014
(10 years ago)
| Expired |
| US6949532
(Pediatric)
| Use of mometasone furoate for treating airway passage and lung diseases |
27 Jul, 2014
(10 years ago)
| Expired |
| US5889015 | Use of mometasone furoate for treating lower airway passage and lung diseases |
27 Jan, 2014
(10 years ago)
| Expired |
| US6057307 | Use of mometasone furoate for treating airway passage and lung diseases |
27 Jan, 2014
(10 years ago)
| Expired |
| US6365581 | Use of mometasone furoate for treating airway passage and lung diseases |
27 Jan, 2014
(10 years ago)
| Expired |
| US6677322 | Use of mometasone furoate for treating airway passage and lung diseases |
27 Jan, 2014
(10 years ago)
| Expired |
| US6949532 | Use of mometasone furoate for treating airway passage and lung diseases |
27 Jan, 2014
(10 years ago)
| Expired |
| US5394868
(Pediatric)
| Inhalation device for powdered medicaments |
25 Dec, 2012
(12 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Asmanex Twisthaler's drug page
3. Clarinex-d 12 Hour
Clarinex-d 12 Hour is protected by 10 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US7618649
(Pediatric)
| Extended release oral dosage composition |
19 Jun, 2021
(3 years ago)
| Expired |
| US6709676 | Extended release oral dosage composition |
18 Feb, 2021
(3 years ago)
| Expired |
| US7618649 | Extended release oral dosage composition |
19 Dec, 2020
(4 years ago)
| Expired |
| US8187630 | Extended release oral dosage composition |
19 Dec, 2020
(4 years ago)
| Expired |
| US6100274
(Pediatric)
| 8-chloro-6,11-dihydro-11- ](4-piperidylidine)-5H-benzo[5,6]cyclohepta[1,2-bpyridine oral compositions |
07 Jan, 2020
(4 years ago)
| Expired |
| US6100274 | 8-chloro-6,11-dihydro-11- ](4-piperidylidine)-5H-benzo[5,6]cyclohepta[1,2-bpyridine oral compositions |
07 Jul, 2019
(5 years ago)
| Expired |
| US7214683
(Pediatric)
| Compositions of descarboethoxyloratadine |
30 Jun, 2015
(9 years ago)
| Expired |
| US7214684
(Pediatric)
| Methods for the treatment of allergic rhinitis |
30 Jun, 2015
(9 years ago)
| Expired |
| US7214683 | Compositions of descarboethoxyloratadine |
30 Dec, 2014
(9 years ago)
| Expired |
| US7214684 | Methods for the treatment of allergic rhinitis |
30 Dec, 2014
(9 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Clarinex-d 12 Hour's drug page
4. Dulera
Dulera is protected by 10 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US7067502
(Pediatric)
| Combinations of formoterol and mometasone furoate for asthma |
21 Nov, 2020
(4 years ago)
| Expired |
| US7566705
(Pediatric)
| Combination of formoterol and mometasone furoate for asthma |
21 Nov, 2020
(4 years ago)
| Expired |
| US7067502 | Combinations of formoterol and mometasone furoate for asthma |
21 May, 2020
(4 years ago)
| Expired |
| US7566705 | Combination of formoterol and mometasone furoate for asthma |
08 May, 2020
(4 years ago)
| Expired |
| US6068832 | Chlorofluorocarbon-free mometasone furoate aerosol formulations |
27 Aug, 2017
(7 years ago)
| Expired |
| US5889015
(Pediatric)
| Use of mometasone furoate for treating lower airway passage and lung diseases |
27 Jul, 2014
(10 years ago)
| Expired |
| US6057307
(Pediatric)
| Use of mometasone furoate for treating airway passage and lung diseases |
27 Jul, 2014
(10 years ago)
| Expired |
| US5889015 | Use of mometasone furoate for treating lower airway passage and lung diseases |
27 Jan, 2014
(10 years ago)
| Expired |
| US6057307 | Use of mometasone furoate for treating airway passage and lung diseases |
27 Jan, 2014
(10 years ago)
| Expired |
| US6677323 | Use of mometasone furoate for treating airway passage and lung diseases |
27 Jan, 2014
(10 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Dulera's drug page
5. Fosamax Plus D
Fosamax Plus D is protected by 8 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US5994329
(Pediatric)
| Method for inhibiting bone resorption |
17 Jan, 2019
(5 years ago)
| Expired |
| US5994329 | Method for inhibiting bone resorption |
17 Jul, 2018
(6 years ago)
| Expired |
| US5358941
(Pediatric)
| Dry mix formulation for bisphosphonic acids with lactose |
02 Jun, 2013
(11 years ago)
| Expired |
| US5681590
(Pediatric)
| Dry mix formulation for bisphosphonic acids |
02 Jun, 2013
(11 years ago)
| Expired |
| US6090410
(Pediatric)
| Dry mix formulation for bisphosphonic acids |
02 Jun, 2013
(11 years ago)
| Expired |
| US5358941 | Dry mix formulation for bisphosphonic acids with lactose |
02 Dec, 2012
(12 years ago)
| Expired |
| US5681590 | Dry mix formulation for bisphosphonic acids |
02 Dec, 2012
(12 years ago)
| Expired |
| US6090410 | Dry mix formulation for bisphosphonic acids |
02 Dec, 2012
(12 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Fosamax Plus D's drug page
Explore Our Curated Drug Screens
6. Maxalt
Maxalt is protected by 2 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US5298520
(Pediatric)
| Triazole containing indole derivatives |
29 Dec, 2012
(12 years ago)
| Expired |
| US5602162
(Pediatric)
| Imidazole, triazole and tetrazole derivatives |
28 Jul, 2012
(12 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Maxalt's drug page
7. Nasonex
Nasonex is protected by 6 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US6127353
(Pediatric)
| Mometasone furoate monohydrate, process for making same and pharmaceutical compositions |
03 Apr, 2018
(6 years ago)
| Expired |
| US6127353 | Mometasone furoate monohydrate, process for making same and pharmaceutical compositions |
03 Oct, 2017
(7 years ago)
| Expired |
| US5837699
(Pediatric)
| Use of mometasone furoate for treating upper airway passage diseases |
27 Jul, 2014
(10 years ago)
| Expired |
| US6723713
(Pediatric)
| Use of mometasone furoate for treating upper airway diseases |
27 Jul, 2014
(10 years ago)
| Expired |
| US5837699 | Use of mometasone furoate for treating upper airway passage diseases |
27 Jan, 2014
(10 years ago)
| Expired |
| US6723713 | Use of mometasone furoate for treating upper airway diseases |
27 Jan, 2014
(10 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Nasonex's drug page
8. Xaciato
Xaciato is protected by 1 patent, which is still active. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11129896 | Topical formulations and treatments |
22 Sep, 2036
(11 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Xaciato's drug page